Brandon G. Smaglo

1.4k total citations
54 papers, 686 citations indexed

About

Brandon G. Smaglo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Brandon G. Smaglo has authored 54 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 16 papers in Cancer Research. Recurrent topics in Brandon G. Smaglo's work include Pancreatic and Hepatic Oncology Research (19 papers), Cancer Genomics and Diagnostics (14 papers) and Gastric Cancer Management and Outcomes (9 papers). Brandon G. Smaglo is often cited by papers focused on Pancreatic and Hepatic Oncology Research (19 papers), Cancer Genomics and Diagnostics (14 papers) and Gastric Cancer Management and Outcomes (9 papers). Brandon G. Smaglo collaborates with scholars based in United States, Sweden and Canada. Brandon G. Smaglo's co-authors include Louis M. Weiner, Dalal Aldeghaither, Michael J. Pishvaian, John L. Marshall, Aiwu Ruth He, Jimmy J. Hwang, Michael J. Overman, Hongkun Wang, Anteneh Tesfaye and Benjamin Musher and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and The Lancet Oncology.

In The Last Decade

Brandon G. Smaglo

50 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brandon G. Smaglo United States	15	368	223	146	136	108	54	686
Quan P. Ly United States	19	405 1.1×	331 1.5×	141 1.0×	177 1.3×	188 1.7×	42	922
Emilio Francesco Giunta Italy	15	386 1.0×	210 0.9×	174 1.2×	108 0.8×	82 0.8×	61	646
Kavitha Balaji United States	9	381 1.0×	320 1.4×	142 1.0×	86 0.6×	105 1.0×	15	829
Jeffrey G. Kuremsky United States	9	297 0.8×	202 0.9×	289 2.0×	113 0.8×	58 0.5×	13	681
Koelina Ganguly United States	16	293 0.8×	328 1.5×	82 0.6×	98 0.7×	167 1.5×	25	630
Giuseppina Della Vittoria Scarpati Italy	15	407 1.1×	438 2.0×	172 1.2×	125 0.9×	313 2.9×	44	973
Ashton A. Connor United States	14	520 1.4×	250 1.1×	94 0.6×	272 2.0×	219 2.0×	50	859
Michela Quirino Italy	12	452 1.2×	240 1.1×	189 1.3×	127 0.9×	77 0.7×	27	767
Konrad Klinghammer Germany	14	310 0.8×	235 1.1×	181 1.2×	74 0.5×	125 1.2×	53	580

Countries citing papers authored by Brandon G. Smaglo

Since Specialization

Citations

This map shows the geographic impact of Brandon G. Smaglo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon G. Smaglo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon G. Smaglo more than expected).

Fields of papers citing papers by Brandon G. Smaglo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon G. Smaglo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon G. Smaglo. The network helps show where Brandon G. Smaglo may publish in the future.

Co-authorship network of co-authors of Brandon G. Smaglo

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon G. Smaglo. A scholar is included among the top collaborators of Brandon G. Smaglo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon G. Smaglo. Brandon G. Smaglo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tzeng, Ching‐Wei D., Laura R. Prakash, Jessica Maxwell, et al.. (2024). Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer. Annals of Surgery. 282(6). 1024–1033. 3 indexed citations

Yousef, Abdelrahman, Mark W. Hurd, Huamin Wang, et al.. (2024). Molecular and clinical features of pancreatic acinar cell carcinoma: A single institutional experience.. Journal of Clinical Oncology. 42(16_suppl). e16335–e16335.

Musher, Benjamin, Eric K. Rowinsky, Brandon G. Smaglo, et al.. (2024). LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study. The Lancet Oncology. 25(4). 488–500. 36 indexed citations

Ludmir, Ethan B., Alexander D. Sherry, Bryan Fellman, et al.. (2024). Addition of metastasis-directed therapy to standard-of-care systemic therapy for oligometastatic pancreatic ductal adenocarcinoma (EXTEND): Results of a multicenter, randomized phase II trial.. Journal of Clinical Oncology. 42(3_suppl). 603–603. 6 indexed citations

Surana, Rishi, Graciela Nogueras González, Jane E. Rogers, et al.. (2023). Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Trials. Journal of Gastrointestinal Cancer. 54(4). 1308–1315. 1 indexed citations

Smaglo, Brandon G.. (2023). Role for Neoadjuvant Systemic Therapy for Potentially Resectable Pancreatic Cancer. Cancers. 15(8). 2377–2377. 5 indexed citations

Ludford, Kaysia, Kanwal Raghav, Mariela A. Blum Murphy, et al.. (2021). Safety and efficacy of neoadjuvant pembrolizumab in mismatch repair deficient localized/locally advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). 2520–2520. 8 indexed citations

Raghav, Kanwal, Hyunsoo Hwang, Alexandre A. Jácome, et al.. (2021). Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary. Clinical Cancer Research. 27(12). 3414–3421. 26 indexed citations

Ludford, Kaysia, Kanwal Pratap Singh Raghav, Michelle Murphy, et al.. (2021). 1758O Neoadjuvant pembrolizumab in localized/locally advanced solid tumors with mismatch repair deficiency. Annals of Oncology. 32. S1210–S1210. 11 indexed citations

10.

Huey, Ryan, Brandon G. Smaglo, Jeannelyn S. Estrella, et al.. (2021). Cancer of Unknown Primary Presenting as Bone-Predominant or Lymph Node-Only Disease: A Clinicopathologic Portrait. The Oncologist. 26(4). e650–e657. 3 indexed citations

11.

Pishvaian, Michael J., Hongkun Wang, Aiwu Ruth He, et al.. (2020). A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer. Clinical Cancer Research. 26(19). 5092–5101. 32 indexed citations

12.

Musher, Benjamin, Brandon G. Smaglo, Wasif M. Abidi, et al.. (2020). A phase I/II study combining a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus and nab-paclitaxel/gemcitabine chemotherapy in advanced pancreatic cancer: An interim report.. Journal of Clinical Oncology. 38(4_suppl). 716–716. 10 indexed citations

13.

Sada, Yvonne H., Brandon G. Smaglo, Hop S. Tran Cao, et al.. (2019). National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer. Journal of Surgical Research. 237. 41–49. 3 indexed citations

14.

Sada, Yvonne H., Hop S. Tran Cao, George J. Chang, et al.. (2018). Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer. Journal of Surgical Research. 226. 15–23. 11 indexed citations

15.

Deeken, John F., Hongkun Wang, Marion L. Hartley, et al.. (2018). A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies. Cancer Chemotherapy and Pharmacology. 81(3). 587–596. 79 indexed citations

16.

Wald, Ori, Brandon G. Smaglo, Henry Mok, & Shawn S. Groth. (2017). Future directions in esophageal cancer therapy. Annals of Cardiothoracic Surgery. 6(2). 159–166. 18 indexed citations

17.

Salem, Mohamed E., Joanne Xiu, Wafik S. El‐Deiry, et al.. (2016). O-005 Comparative molecular analyses of esophageal adenocarcinoma, esophageal squamous cell carcinoma, and gastric adenocarcinoma, and impact of molecular profile on outcome. Annals of Oncology. 27. ii119–ii119. 2 indexed citations

18.

Pishvaian, Michael J. & Brandon G. Smaglo. (2014). Profile and potential of ixabepilone in the treatment of pancreatic cancer. Drug Design Development and Therapy. 8. 923–923. 8 indexed citations

19.

He, Aiwu Ruth, Anteneh Tesfaye, Daniel J. Smith, et al.. (2014). Phase II trial of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 32(3_suppl). 240–240. 6 indexed citations

20.

Smaglo, Brandon G. & John L. Marshall. (2013). Microsatellite instability in colorectal cancer.. PubMed. 11(10). 659–61. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact